UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

FOR THE MONTH OF NOVEMBER 2023

COMMISSION FILE NUMBER 001-34041

Evotec SE
(Translation of registrant’s name into English)

Essener Bogen 7

22419 Hamburg

Germany

Tel: +49 40 560810
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F: Form 20-F x Form 40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

On November 8, 2023, Evotec SE (the “Company”) announced the financial results and corporate updates for the first nine months 2023. The Interim Statement 9M 2023 is attached hereto as Exhibit 99.1. An accompanying press release is attached hereto as Exhibit 99.2.

SIGNATURE

Pursuant to the requirements of the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Evotec SE
By:	/s/ Laetitia Rouxel
	Name: Laetitia Rouxel
	Title: Chief Financial Officer

Date: November 8, 2023

EXHIBIT INDEX

Exhibit	Description of Exhibit
99.1	Evotec SE Interim statement first nine months dated November 8, 2023
99.2	Evotec SE Press Release dated November 8, 2022